INVIVO THERAPEUTICS HLDGS CO's ticker is and the CUSIP is 46186M605. A total of 14 filers reported holding INVIVO THERAPEUTICS HLDGS CO in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $0 | – | 1 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ROYAL BANK OF CANADA | 70 | $0 | 0.00% |
| UBS Group AG | 1 | $0 | 0.00% |
| IFP Advisors, Inc | 1 | $1,000 | 0.00% |
| Sugarloaf Wealth Management, LLC | 1 | $0 | 0.00% |
| OSAIC HOLDINGS, INC. | 7 | $0 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 1 | $0 | 0.00% |
| WELLS FARGO & COMPANY/MN | 9 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 11,046 | $44,000 | 0.00% |
| MORGAN STANLEY | 1,154 | $5,000 | 0.00% |